Literature DB >> 7965243

A simple strategy to improve patient adherence to outpatient fecal occult blood testing.

J D Freedman1, C K Mitchell.   

Abstract

Poor patient adherence reduces the effectiveness of fecal occult blood testing for colon cancer. Patients at the inner-city clinic involved in the study have historically completed only one-third of the tests administered to them. The authors studied three ways of returning test kits (by hand, by mail, and by mail with prepaid postage). Among 146 randomly assigned patients, the completion rates were 37%, 57%, and 71%, respectively. The difference was significant between the first and third groups (p = 0.003), and the cost was less for the third group ($1.71 vs $2.24 per completed test). The authors recommend that clinics serving indigent populations use postage-paid return envelopes with fecal occult blood testing to improve its effectiveness and save money.

Entities:  

Mesh:

Year:  1994        PMID: 7965243     DOI: 10.1007/BF02599066

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

1.  Participation in mass screening for colorectal cancer with fecal occult blood test.

Authors:  K Klaaborg; M S Madsen; O Søndergaard; O Kronborg
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

2.  Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital.

Authors:  S J Sontag; C Durczak; G V Aranha; G Chejfec; W Frederick; H B Greenlee
Journal:  Am J Surg       Date:  1983-01       Impact factor: 2.565

3.  Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.

Authors:  S Adamsen; O Kronborg
Journal:  Scand J Gastroenterol       Date:  1984-06       Impact factor: 2.423

4.  Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.

Authors:  O Kronborg; C Fenger; O Søndergaard; K M Pedersen; J Olsen
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

5.  Screening for asymptomatic bowel cancer in general practice.

Authors:  R C Lallemand; P A Vakil; P Pearson; V Box
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

6.  Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.

Authors:  A C Marcus; L A Crane; C P Kaplan; A E Reading; E Savage; J Gunning; G Bernstein; J S Berek
Journal:  Med Care       Date:  1992-03       Impact factor: 2.983

7.  Comparative educational approaches to screening for colorectal cancer.

Authors:  T W Elwood; A Erickson; S Lieberman
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

8.  Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

9.  Patient compliance with screening for fecal occult blood in family practice.

Authors:  P E Hoogewerf; T G Hislop; B J Morrison; S D Burns; R Sizto
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

10.  Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.

Authors:  F A Macrae; D J St John; A Ambikapathy; K Sharpe; J F Garner
Journal:  Med J Aust       Date:  1986-06-09       Impact factor: 7.738

View more
  7 in total

1.  A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon
Journal:  Cancer       Date:  2017-07-28       Impact factor: 6.860

Review 2.  Organizational factors and the cancer screening process.

Authors:  Rebecca Anhang Price; Jane Zapka; Heather Edwards; Stephen H Taplin
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.

Authors:  Amit G Singal; Jasmin A Tiro; Samir Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

4.  Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.

Authors:  Jennifer E Boehm; Elizabeth A Rohan; Judith Preissle; Amy DeGroff; Rebecca Glover-Kudon
Journal:  Cancer       Date:  2013-08-01       Impact factor: 6.860

5.  An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.

Authors:  Beverly B Green; Ching-Yun Wang; Melissa L Anderson; Jessica Chubak; Richard T Meenan; Sally W Vernon; Sharon Fuller
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

6.  A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon
Journal:  J Gen Intern Med       Date:  2021-05-28       Impact factor: 6.473

Review 7.  Public awareness of colorectal cancer screening: knowledge, attitudes, and interventions for increasing screening uptake.

Authors:  Antonio Z Gimeno Garcia; Noemi Hernandez Alvarez Buylla; David Nicolas-Perez; Enrique Quintero
Journal:  ISRN Oncol       Date:  2014-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.